STOCK TITAN

[Form 4] Eastman Chemical Company Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Positive)
Form Type
4
Rhea-AI Filing Summary

Julie Fasone, a director of Eastman Chemical Company (EMN), purchased 1,453 shares of the company's common stock on 08/27/2025 at a reported price of $68.8 per share. After this purchase she beneficially owned 17,546 shares in a direct ownership capacity. The Form 4 was filed as a single reporting person filing and the form was signed on behalf of Ms. Fasone by Mark D. Austin by power of attorney on 08/28/2025. The report discloses no derivative transactions and provides no additional remarks.

Julie Fasone, membro del consiglio di amministrazione di Eastman Chemical Company (EMN), ha acquistato 1.453 azioni ordinarie della società il 27/08/2025 al prezzo riportato di $68,8 per azione. Dopo questo acquisto deteneva effettivamente 17.546 azioni a titolo di proprietà diretta. Il Form 4 è stato presentato come deposito di un unico soggetto dichiarante e il modulo è stato firmato per conto della Sig.ra Fasone da Mark D. Austin mediante procura il 28/08/2025. Il rapporto non segnala operazioni su strumenti derivati e non contiene ulteriori annotazioni.

Julie Fasone, directora de Eastman Chemical Company (EMN), compró 1.453 acciones ordinarias de la compañía el 27/08/2025 a un precio declarado de $68,8 por acción. Tras esta compra poseía beneficiariamente 17.546 acciones en calidad de titular directo. El Formulario 4 fue presentado como una declaración de una sola persona informante y el formulario fue firmado en nombre de la Sra. Fasone por Mark D. Austin mediante poder notarial el 28/08/2025. El informe no revela transacciones derivadas ni aporta observaciones adicionales.

Eastman Chemical Company(EMN) 이사인 Julie Fasone은 2025년 8월 27일 회사 보통주 1,453주를 주당 $68.8로 매수했습니다. 해당 매수 후 그녀는 직접 소유 형태로 총 17,546주를 실질적으로 보유하게 되었습니다. Form 4는 단일 보고자 제출로 접수되었고, 해당 서류는 2025년 8월 28일 위임장(파워 오브 어토니)을 통해 Mark D. Austin이 Fasone 씨를 대신해 서명했습니다. 보고서에는 파생상품 거래가 없고 추가 언급도 없습니다.

Julie Fasone, administratrice d'Eastman Chemical Company (EMN), a acheté 1 453 actions ordinaires de la société le 27/08/2025 au prix déclaré de 68,8 $ par action. Après cet achat, elle détenait effectivement 17 546 actions en propriété directe. Le Formulaire 4 a été déposé en tant que déclaration d'une seule personne déclarante et le formulaire a été signé au nom de Mme Fasone par Mark D. Austin par procuration le 28/08/2025. Le rapport n'indique aucune transaction sur produits dérivés et ne contient pas de remarques supplémentaires.

Julie Fasone, Direktorin von Eastman Chemical Company (EMN), erwarb am 27.08.2025 1.453 Stammaktien des Unternehmens zu einem angegebenen Preis von $68,8 je Aktie. Nach diesem Kauf besaß sie wirtschaftlich 17.546 Aktien in direktem Eigentum. Das Form 4 wurde als Meldung einer einzelnen meldepflichtigen Person eingereicht, und das Formular wurde am 28.08.2025 im Namen von Frau Fasone von Mark D. Austin per Vollmacht unterzeichnet. Der Bericht gibt keine Derivatgeschäfte an und enthält keine weiteren Bemerkungen.

Positive
  • Director purchase reported, indicating direct insider acquisition of 1,453 shares
  • Clear disclosure of post-transaction ownership: 17,546 shares held directly
  • No derivatives involved, simplifying ownership picture
Negative
  • None.

Insights

TL;DR: Routine insider purchase by a director; standard Form 4 disclosure with direct beneficial ownership increase.

The filing documents a common, straightforward acquisition by a board director. The purchase increases the director's direct shareholdings to 17,546 shares and is disclosed under Section 16(a). There are no derivative transactions, no amendments, and the filing was executed via power of attorney. For governance, this is a standard, transparent disclosure consistent with reporting obligations.

TL;DR: Insider purchase reported; transaction details are clear and routine, providing limited market-moving information.

The Form 4 reports acquisition of 1,453 common shares at $68.8 each on 08/27/2025, raising direct beneficial ownership to 17,546 shares. The absence of derivative activity and lack of explanatory remarks indicate a single open-market or plan purchase reported under the appropriate transaction code. The disclosure fulfills regulatory requirements but contains no additional material financial data.

Julie Fasone, membro del consiglio di amministrazione di Eastman Chemical Company (EMN), ha acquistato 1.453 azioni ordinarie della società il 27/08/2025 al prezzo riportato di $68,8 per azione. Dopo questo acquisto deteneva effettivamente 17.546 azioni a titolo di proprietà diretta. Il Form 4 è stato presentato come deposito di un unico soggetto dichiarante e il modulo è stato firmato per conto della Sig.ra Fasone da Mark D. Austin mediante procura il 28/08/2025. Il rapporto non segnala operazioni su strumenti derivati e non contiene ulteriori annotazioni.

Julie Fasone, directora de Eastman Chemical Company (EMN), compró 1.453 acciones ordinarias de la compañía el 27/08/2025 a un precio declarado de $68,8 por acción. Tras esta compra poseía beneficiariamente 17.546 acciones en calidad de titular directo. El Formulario 4 fue presentado como una declaración de una sola persona informante y el formulario fue firmado en nombre de la Sra. Fasone por Mark D. Austin mediante poder notarial el 28/08/2025. El informe no revela transacciones derivadas ni aporta observaciones adicionales.

Eastman Chemical Company(EMN) 이사인 Julie Fasone은 2025년 8월 27일 회사 보통주 1,453주를 주당 $68.8로 매수했습니다. 해당 매수 후 그녀는 직접 소유 형태로 총 17,546주를 실질적으로 보유하게 되었습니다. Form 4는 단일 보고자 제출로 접수되었고, 해당 서류는 2025년 8월 28일 위임장(파워 오브 어토니)을 통해 Mark D. Austin이 Fasone 씨를 대신해 서명했습니다. 보고서에는 파생상품 거래가 없고 추가 언급도 없습니다.

Julie Fasone, administratrice d'Eastman Chemical Company (EMN), a acheté 1 453 actions ordinaires de la société le 27/08/2025 au prix déclaré de 68,8 $ par action. Après cet achat, elle détenait effectivement 17 546 actions en propriété directe. Le Formulaire 4 a été déposé en tant que déclaration d'une seule personne déclarante et le formulaire a été signé au nom de Mme Fasone par Mark D. Austin par procuration le 28/08/2025. Le rapport n'indique aucune transaction sur produits dérivés et ne contient pas de remarques supplémentaires.

Julie Fasone, Direktorin von Eastman Chemical Company (EMN), erwarb am 27.08.2025 1.453 Stammaktien des Unternehmens zu einem angegebenen Preis von $68,8 je Aktie. Nach diesem Kauf besaß sie wirtschaftlich 17.546 Aktien in direktem Eigentum. Das Form 4 wurde als Meldung einer einzelnen meldepflichtigen Person eingereicht, und das Formular wurde am 28.08.2025 im Namen von Frau Fasone von Mark D. Austin per Vollmacht unterzeichnet. Der Bericht gibt keine Derivatgeschäfte an und enthält keine weiteren Bemerkungen.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Holder Julie Fasone

(Last) (First) (Middle)
200 S. WILCOX DRIVE

(Street)
KINGSPORT TN 37660

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
EASTMAN CHEMICAL CO [ EMN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/27/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/27/2025 P 1,453 A $68.8 17,546 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
/s/ Mark D. Austin, by Power of Attorney for Julie Fasone Holder 08/28/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Julie Fasone report on Form 4 for EMN?

The Form 4 reports that Julie Fasone acquired 1,453 shares of Eastman Chemical Company common stock on 08/27/2025.

At what price were the EMN shares acquired according to the filing?

The reported purchase price was $68.8 per share.

How many EMN shares does Julie Fasone beneficially own after the reported transaction?

Following the transaction, she beneficially owned 17,546 shares in a direct capacity.

Was the Form 4 filed individually or jointly for this EMN transaction?

The filing indicates it was a Form filed by One Reporting Person (individual filing).

Who signed the Form 4 on behalf of Julie Fasone and when?

The Form 4 was signed by Mark D. Austin, by Power of Attorney for Julie Fasone on 08/28/2025.
Eastman Chem Co

NYSE:EMN

EMN Rankings

EMN Latest News

EMN Latest SEC Filings

EMN Stock Data

7.90B
113.84M
0.76%
92%
2.32%
Specialty Chemicals
Plastic Materials, Synth Resins & Nonvulcan Elastomers
Link
United States
KINGSPORT